Your browser doesn't support javascript.
loading
Compact Cas9d and HEARO enzymes for genome editing discovered from uncultivated microbes.
Aliaga Goltsman, Daniela S; Alexander, Lisa M; Lin, Jyun-Liang; Fregoso Ocampo, Rodrigo; Freeman, Benjamin; Lamothe, Rebecca C; Perez Rivas, Andres; Temoche-Diaz, Morayma M; Chadha, Shailaja; Nordenfelt, Natalie; Janson, Owen P; Barr, Ian; Devoto, Audra E; Cost, Gregory J; Butterfield, Cristina N; Thomas, Brian C; Brown, Christopher T.
Afiliação
  • Aliaga Goltsman DS; Metagenomi Inc. 1545 Park Ave, Emeryville, CA, 94608, USA. daniela@metagenomi.co.
  • Alexander LM; Metagenomi Inc. 1545 Park Ave, Emeryville, CA, 94608, USA.
  • Lin JL; Metagenomi Inc. 1545 Park Ave, Emeryville, CA, 94608, USA.
  • Fregoso Ocampo R; Metagenomi Inc. 1545 Park Ave, Emeryville, CA, 94608, USA.
  • Freeman B; Metagenomi Inc. 1545 Park Ave, Emeryville, CA, 94608, USA.
  • Lamothe RC; Metagenomi Inc. 1545 Park Ave, Emeryville, CA, 94608, USA.
  • Perez Rivas A; Metagenomi Inc. 1545 Park Ave, Emeryville, CA, 94608, USA.
  • Temoche-Diaz MM; Metagenomi Inc. 1545 Park Ave, Emeryville, CA, 94608, USA.
  • Chadha S; Metagenomi Inc. 1545 Park Ave, Emeryville, CA, 94608, USA.
  • Nordenfelt N; Metagenomi Inc. 1545 Park Ave, Emeryville, CA, 94608, USA.
  • Janson OP; Metagenomi Inc. 1545 Park Ave, Emeryville, CA, 94608, USA.
  • Barr I; Metagenomi Inc. 1545 Park Ave, Emeryville, CA, 94608, USA.
  • Devoto AE; Metagenomi Inc. 1545 Park Ave, Emeryville, CA, 94608, USA.
  • Cost GJ; Metagenomi Inc. 1545 Park Ave, Emeryville, CA, 94608, USA.
  • Butterfield CN; Metagenomi Inc. 1545 Park Ave, Emeryville, CA, 94608, USA.
  • Thomas BC; Metagenomi Inc. 1545 Park Ave, Emeryville, CA, 94608, USA.
  • Brown CT; Metagenomi Inc. 1545 Park Ave, Emeryville, CA, 94608, USA. ctb@metagenomi.co.
Nat Commun ; 13(1): 7602, 2022 12 15.
Article em En | MEDLINE | ID: mdl-36522342
ABSTRACT
Programmable, RNA-guided nucleases are diverse enzymes that have been repurposed for biotechnological applications. However, to further expand the therapeutic application of these tools there is a need for targetable systems that are small enough to be delivered efficiently. Here, we mined an extensive genome-resolved metagenomics database and identified families of uncharacterized RNA-guided, compact nucleases (between 450 and 1,050 aa). We report that Cas9d, a new CRISPR type II subtype, contains Zinc-finger motifs and high arginine content, features that we also found in nucleases related to HEARO effectors. These enzymes exhibit diverse biochemical characteristics and are broadly targetable. We show that natural Cas9d enzymes are capable of genome editing in mammalian cells with >90% efficiency, and further engineered nickase variants into the smallest base editors active in E. coli and human cells. Their small size, broad targeting potential, and translatability suggest that Cas9d and HEARO systems will enable a variety of genome editing applications.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escherichia coli / Edição de Genes Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escherichia coli / Edição de Genes Idioma: En Ano de publicação: 2022 Tipo de documento: Article